Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Protea and CyVek

Premium

Protea Biosciences announced this week that it has appointed Thijs Spoor and Josiah Austin to its board of directors.

Spoor is currently chairman of the board, CEO, and president of FluoroPharma Medical. Previously he was chief financial officer for Sunstone Biosciences.

Austin is currently the managing member of El Coronado Holdings. He previously served on the boards of Monterey Bay Bancorp, New York Bancorp, and North Forth Bancorporation.


CyVek this week appointed Sheila Burns vice president of sales and marketing.

Burns was previously senior director of global strategic marketing at Luminex and before that held senior level positions at Life Technologies and Thermo Fisher Scientific.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.